Svetlana V. Villevalde
St
Saint Petersburg, SPE, Russian Federation
Saint Petersburg, SPE, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Russian eligibility criteria for prescription of menopausal hormone therapy to patients with cardiovascular and metabolic diseases. Agreement document of RKO, ROAG, RAE, EAT, AFR, RNMOT, RAGG
Journal: Problemy endokrinologii
Published: December 12, 2025
Russian Eligibility Criteria for Prescribing Menopausal Hormone Therapy to Patients With Cardiovascular and Metabolic Diseases. Consensus Document of RSC, RSOG, RAE, EUAT, RAP, RSMSI, RAGG
Journal: Kardiologiia
Published: October 06, 2025
Menopausal hormone therapy in patients with cardiovascular and metabolic diseases: an interdisciplinary Delphi consensus among Russian gynecologists, cardiologists, endocrinologists, gerontologists and geriatricians, phlebologists, and clinical pharmacologists
Journal: Terapevticheskii arkhiv
Published: September 27, 2025
Acetazolamide per os in Decompensated Chronic Heart Failure: Randomized Multicenter Trial ORION-A.
Journal: Journal of clinical medicine
Published: August 27, 2025
Profiling hypotension in heart failure based on office, orthostatic and ambulatory blood pressure measurements.
Journal: European journal of heart failure
Published: April 01, 2025
Cumulative Incidence and Prognostic Value of Readmissions in Patients With Heart Failure: Data From a Large Cohort Study of Real Clinical Practice in St. Petersburg.
Journal: Kardiologiia
Published: October 06, 2024
Russian eligibility criteria prescribing menopausal hormonal hormones therapy for patients with cardiovascular and metabolic diseases. Consensus document of the Russian Cardiological Society, Russian Society of Obstetricians and Gynecologists, Russian Association of Endocrinologists, Eurasian Association of Therapists, Association of Phlebologists of Russia
Journal: Problemy endokrinologii
Published: October 30, 2023
Russian Eligibility Criteria for Prescribing Menopausal Hormone Therapy to Patients With Cardiovascular and Metabolic Diseases. Consensus Document of RSC, RSOG, RAE, EUAT, RAP
Journal: Kardiologiia
Published: July 24, 2023
Blood Pressure Response and Symptoms During Active Standing Test Among Hospitalized and Outpatients With Heart Failure: Results From the GRAVITY-HF Prospective Observational Cohort Study.
Journal: Journal of cardiac failure
Published: July 11, 2023
Cardiovascular effects of omega-3 polyunsaturated fatty acids: position of omega-3 polyunsaturated fatty acids in Russian and international guidelines. Council of Experts
Journal: Kardiologiia
Published: December 29, 2022
Empagliflozin and heart failure: position paper of the experts on the results of the online meeting and discussion of the EMPEROR-Preserved Trial
Journal: Terapevticheskii arkhiv
Published: January 15, 2022
Decompensated heart failure with reduced ejection fraction: overcoming barriers to improve prognosis in the "vulnerable" period after discharge
Journal: Kardiologiia
Published: October 05, 2021
Last Updated: 09/26/2026